There is no single “best” medicine for anxiety and depression, but two classes of medication consistently come out on top across clinical guidelines: SSRIs and SNRIs. These are the recommended first-line treatments for both conditions, which makes them especially useful when anxiety and depression overlap. The specific medication that works best for you depends on your symptom profile, how your body responds, and what side effects you can tolerate.
SSRIs and SNRIs: The First-Line Options
SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors) are the pharmacologic treatment of choice for major depression, generalized anxiety disorder, panic disorder, and social anxiety disorder. That across-the-board effectiveness is why they dominate treatment guidelines from psychiatric organizations in the U.S., Canada, and Europe.
SSRIs work by increasing the availability of serotonin in the brain. SNRIs do the same thing but also boost norepinephrine, a second chemical messenger involved in energy, alertness, and mood regulation. Research suggests that this dual action may give SNRIs a slight edge in efficacy over SSRIs for some people, though both classes work well.
The SSRIs with the most evidence and FDA approvals across anxiety and depression include sertraline, escitalopram, paroxetine, and fluoxetine. Among SNRIs, venlafaxine and duloxetine are the most widely studied and prescribed. Escitalopram, for example, is FDA-approved for both major depression and generalized anxiety at a starting dose of 10 mg once daily. If you and your prescriber decide to try one, the choice often comes down to side effect profiles and practical considerations rather than dramatic differences in effectiveness.
How These Medications Actually Work
Both SSRIs and SNRIs increase the concentration of mood-regulating chemicals in the gaps between nerve cells in your brain. This initial chemical shift happens quickly, but it triggers a slower chain of biological changes, including the growth of new nerve cells and the strengthening of signaling pathways. Those downstream adaptations are why these medications take time to work.
Studies suggest the average onset of noticeable improvement is about 13 days, but reaching full therapeutic effect typically takes longer, around 20 days or more. A sustained, reliable response generally requires two to three weeks of consistent treatment. Remission, where symptoms resolve almost entirely, may take 10 to 14 weeks, and only a minority of patients reach that milestone within that window. The slow ramp-up can be frustrating, but it reflects real biological remodeling rather than a simple chemical switch being flipped.
Common Side Effects to Expect
In a survey of roughly 700 patients taking SSRIs, 38% reported experiencing at least one side effect. The three most commonly mentioned were sexual dysfunction, sleepiness, and weight gain. That said, only about a quarter of those who experienced side effects rated them as “very bothersome” or “extremely bothersome,” meaning most people tolerate these medications reasonably well.
SNRIs share many of the same side effects as SSRIs but can also raise blood pressure in some people, particularly at higher doses. Nausea and headache tend to be more common in the first week or two and often fade. Sexual side effects, unfortunately, tend to persist for as long as you take the medication. If a particular side effect is a dealbreaker, switching to a different drug within the same class or trying an alternative class often helps.
When SSRIs and SNRIs Aren’t Enough
Not everyone responds adequately to a first-line medication. When that happens, there are several well-studied options. Buspirone, an anti-anxiety medication that works on serotonin receptors differently than SSRIs, can be added as an augmentation strategy. In the large STAR*D trial, patients with depression who hadn’t improved after 12 weeks on an SSRI achieved about a 30% remission rate when buspirone was added for an average of nine weeks. A separate study found that adding buspirone to fluoxetine or citalopram produced significantly greater symptom reduction than placebo, especially in patients with more severe symptoms.
Low-dose atypical antipsychotics and mood stabilizers are another augmentation route. Roughly 19% of patients in one large observational study were taking one of these alongside their primary antidepressant, suggesting a meaningful portion of people need combination treatment.
Alternatives That Target Specific Symptoms
Two atypical antidepressants deserve attention because they’re chosen based on the specific symptoms you’re dealing with, not just “anxiety” or “depression” as broad categories.
Bupropion works on dopamine and norepinephrine rather than serotonin. It’s particularly effective if your depression involves excessive sleepiness, fatigue, weight gain, or increased appetite. In clinical comparisons, bupropion outperformed other antidepressants on all four of those symptoms. It also has a lower risk of sexual side effects and weight gain compared to SSRIs. The trade-off: bupropion is not typically effective for anxiety on its own and can sometimes worsen it.
Mirtazapine takes the opposite approach. It’s the better choice if you’re dealing with insomnia, weight loss, or poor appetite, as it tends to increase both sleep and appetite. In head-to-head comparisons, mirtazapine outperformed other antidepressants for insomnia, decreased weight, and decreased appetite. It’s sedating, which can be a benefit or a drawback depending on your situation.
What Stopping Medication Looks Like
About half of patients who try to discontinue or reduce their antidepressant dose experience withdrawal symptoms. These can include flu-like feelings, dizziness, irritability, mood dips, fatigue, bouts of crying, and a distinctive sensation often described as “brain zaps” or electric shock feelings in the head.
Clinical guidelines almost universally recommend tapering gradually rather than stopping abruptly, but the specifics vary widely. Recommended taper durations range from at least four weeks to six months. Some guidelines suggest halving the dose as a first step, then reducing more slowly in smaller increments, allowing about two weeks at each lower dose. A newer approach called hyperbolic tapering, where dose reductions get progressively smaller as you approach zero, shows early promise for reducing withdrawal symptoms. The key point: never stop these medications cold turkey, and expect the process to take longer than you might assume.
How to Think About Choosing a Medication
The honest reality is that finding the right medication often involves some trial and error. No blood test or brain scan can predict which drug will work best for you. What clinicians use instead is your symptom profile. If anxiety is dominant, an SSRI like sertraline or escitalopram is a common starting point. If fatigue and low motivation are prominent alongside depression, an SNRI like duloxetine or an atypical like bupropion might make more sense. If insomnia is severe, mirtazapine could be the first choice.
Your medical history matters too. If a close family member responded well to a particular antidepressant, you’re more likely to respond to the same one. Prior experience with side effects guides the decision as well. Someone who gained significant weight on one SSRI might do better on bupropion, which tends to be weight-neutral or even associated with modest weight loss.
Medication also works best alongside therapy, particularly cognitive behavioral therapy, which has strong evidence for both anxiety and depression. Most treatment guidelines recommend the combination over either approach alone, especially for moderate to severe symptoms.